Trilipix

DRUG2 trials

Sponsors

University of Utah, Piedmont Healthcare

Conditions

Coronary AtherosclerosisDyslipidemia

Phase 3

AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis

WithdrawnNCT01030328

Piedmont HealthcareCoronary Atherosclerosis

Start: 2009-11-30End: 2011-07-31Updated: 2024-12-18

Phase 4

Study of Trilipix Effects on Lipids and Arteries

TerminatedNCT01025492

University of UtahDyslipidemia

Start: 2009-11-30End: 2011-03-31Updated: 2016-09-01